As H19 rs2839698 was shown to contribute to RCC progression, we then sought to explore the association between rs2839698 polymorphism and survival of RCC patients using the Log-rank test and Kaplan-Meier analysis. This evidence concerns the gene H19 and renal cell adenocarcinoma.